V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190005435 | 190001006 | 1.81 | 65.5 | Palliative (P) | 2017-12-19 | 2018-01-09 | ECX | 02 | N | CAPECITABINE + OXALIPLATIN | 100308202 |
| 190005436 | 190001007 | 1.77 | 62.5 | Curative (C) | 2017-01-06 | 2017-02-09 | Carboplatin + Etoposide IV 3 day | 02 | Y | CARBOPLATIN + ETOPOSIDE | 100394490 |
| 190005447 | 190001010 | 1.88 | 71 | Neo-adjuvant (N) | 2016-07-28 | 2016-08-12 | CAPECITABINE + CARBOPLATIN + Cetuximab | 02 | N | OXALIPLATIN + MDG | 100791567 |
| 190005451 | 190001012 | null | null | null | null | 2017-02-14 | EW EuroEwing 2012 Arm A VIDE | null | null | EW EUROEWING 2012 ARM B VDC | 101327941 |
| 190005464 | 190001018 | 1.61 | 46.4 | Curative (C) | 2016-06-18 | 2016-06-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101637183 |
| 190005469 | 190001019 | null | null | null | null | 2019-07-29 | EW EuroEwing 2012 Arm B VDC | null | null | CAPECITABINE + MITOMYCIN | 101640578 |
| 190005474 | 190001020 | 1.66 | 71.9 | Palliative (P) | 2019-01-15 | 2019-01-25 | LANREOTIDE | 02 | N | ECX | 100824565 |
| 190005475 | 190001021 | 1.63 | 99.8 | null | null | 2015-01-22 | Dox + HD Mtx (post PAM) | 02 | null | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100208632 |
| 190005476 | 190001022 | 1.67 | 56.6 | 03 | 2019-10-24 | 2019-10-31 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | null | CISPLATIN + GEMCITABINE | 100372947 |
| 190005482 | 190001023 | 1.65 | 57.6 | Palliative (P) | 2016-06-01 | 2016-10-11 | ECX | N | N | CAPECITABINE + OXALIPLATIN | 100242476 |
| 190005484 | 190001025 | null | null | null | null | 2018-11-05 | LIPOSOMAL DOXORUBICIN | null | null | OCTREOTIDE | 100008683 |
| 190005489 | 190001026 | 1.74 | 103 | null | 2019-12-02 | 2019-12-06 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101427273 |
| 190005498 | 190001029 | 1.78 | 12.4 | Curative (C) | 2019-02-21 | 2019-02-22 | Carboplatin + Etoposide iv&po | N | N | EOX | 101319344 |
| 190005503 | 190001030 | 1.8 | 28.4 | Curative (C) | 2017-01-10 | 2017-01-24 | Cisplatin+Gemcitabine (gallbladder) | 02 | Y | CISPLATIN + GEMCITABINE | 100087470 |
| 190005505 | 190001032 | null | null | null | null | 2018-05-31 | OST Euramos 1 Closed Trial - Ai | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100671246 |
| 190005508 | 190001035 | 1.67 | 103 | Palliative (P) | 2019-04-24 | 2019-05-06 | Bevacizumab+Carbo+Pacliaxel | 02 | N | CISPLATIN + ETOPOSIDE | 101159688 |
| 190005510 | 190001036 | 1.54 | null | Palliative (P) | 2020-01-11 | 2020-01-19 | ECX | 01 | N | DOCETAXEL | 101638118 |
| 190005521 | 190001038 | null | null | null | null | 2019-09-14 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101455585 |
| 190005522 | 190001039 | 1.07 | 102 | 03 | 2017-07-29 | 2017-07-30 | Trial Unspecified | 02 | N | CARBOPLATIN | 101213226 |
| 190005523 | 190001040 | null | null | null | null | 2017-12-06 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101351195 |
| 190005530 | 190001043 | 1.69 | 59 | Neo-adjuvant (N) | 2019-09-21 | 2019-09-21 | Sunitinib | 2 | null | TRIAL UNSPECIFIED | 100286929 |
| 190005531 | 190001044 | null | null | null | null | 2016-12-22 | VIDE | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100435023 |
| 190005533 | 190001045 | 1.61 | 51.4 | Curative (C) | 2019-01-22 | 2019-01-30 | Oxaliplatin + Modified de Gramont | null | N | CISPLATIN + RT | 101165899 |
| 190005536 | 190001046 | null | null | null | null | 2018-08-21 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100026062 |
| 190005540 | 190001047 | null | null | null | null | 2018-09-07 | Doxorubicin 75mg/m2 | null | null | CISPLATIN + DOXORUBICIN | 101260179 |
| 190005546 | 190001050 | null | null | null | null | 2019-07-01 | Trial Unspecified | null | null | PAZOPANIB | 101399858 |
| 190005549 | 190001051 | 1.62 | 99 | Adjuvant (A) | 2016-09-11 | 2016-09-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101225952 |
| 190005551 | 190001052 | null | null | null | null | 2017-03-23 | GEMCITABINE | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101042372 |
| 190005552 | 190001053 | 1.77 | 54.7 | Palliative (P) | 2018-12-02 | 2018-12-12 | FLUOROURACIL + OXALIPLATIN | 02 | N | CARBOPLATIN + DOCETAXEL | 100670168 |
| 190005553 | 190001054 | null | null | null | null | 2020-08-13 | Capecitabine (21days) + Carboplatin | null | null | CISPLATIN + FLUOROURACIL | 100477593 |
| 190005554 | 190001055 | 0 | 0 | Adjuvant (A) | 2019-12-05 | 2019-12-06 | EW EuroEwing 2012 Arm B IE | 02 | N | CNS ATRT DOX | 101301163 |
| 190005555 | 190001056 | null | null | null | null | 2018-02-25 | Dox + HD Mtx (post PAM) | null | null | TEMOZOLOMIDE | 101144089 |
| 190005556 | 190001057 | 0 | 30.3 | Palliative (P) | 2016-01-24 | 2016-02-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100119866 |
| 190005560 | 190001058 | 1.56 | 65.8 | Curative (C) | 2019-04-16 | 2019-04-18 | Everolimus 10mg | N | N | CAPECITABINE + TEMOZOLOMIDE | 100810248 |
| 190005564 | 190001060 | 0 | 4.4 | Palliative (P) | 2016-05-12 | 2016-06-16 | Trial Unspecified | N | N | CISPLATIN + FLUOROURACIL | 100261208 |
| 190005572 | 190001066 | null | null | null | null | 2016-04-23 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 101474549 |
| 190005574 | 190001067 | 1.63 | 48.4 | Palliative (P) | 2016-02-21 | 2016-02-28 | Doxorubicin + Ifosfamide | 01 | N | CARBOPLATIN + GEMCITABINE | 100687796 |
| 190005576 | 190001068 | null | 74 | null | 2017-12-24 | 2018-01-08 | Dox + HD Mtx (post PAM) | 02 | null | CISPLATIN + FLUOROURACIL | 101160500 |
| 190005578 | 190001069 | null | null | null | null | 2018-01-03 | OST Euramos 1 Closed Trial - AP | null | null | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101132135 |
| 190005581 | 190001071 | 0 | 48 | Palliative (P) | 2017-11-13 | 2017-11-20 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101193596 |
| 190005583 | 190001072 | 1.88 | 74.65 | null | 2019-01-08 | 2019-01-20 | Paclitaxel 7 day | 02 | null | CARBOPLATIN | 100527246 |
| 190005586 | 190001073 | null | null | null | 2019-11-22 | 2019-12-06 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 101558939 |
| 190005597 | 190001077 | 0 | 37.9 | Curative (C) | 2013-10-14 | 2013-10-19 | Carboplatin AUC 2 - 5 | 02 | N | DOCETAXEL | 101013694 |
| 190005600 | 190001079 | 1.72 | 50 | Curative (C) | 2017-11-01 | 2017-11-27 | CARBOPLATIN + PACLITAXEL | 01 | N | CARBOPLATIN + PACLITAXEL | 100917789 |
| 190005602 | 190001080 | 1.6 | 53.9 | Curative (C) | 2017-04-16 | 2017-04-16 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | CISPLATIN + GEMCITABINE | 100931936 |
| 190005608 | 190001083 | null | null | null | null | 2018-08-31 | Carboplatin + Etoposide IV 3 day | null | null | CARBOPLATIN + ETOPOSIDE | 101785955 |
| 190005614 | 190001085 | 1.62 | 75.7 | Neo-adjuvant (N) | 2016-06-27 | 2016-07-25 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100907016 |
| 190005619 | 190001086 | null | null | null | null | 2016-11-12 | ECX | null | null | EVEROLIMUS | 101288610 |
| 190005621 | 190001087 | 1.78 | 69.3 | Curative (C) | 2016-11-22 | 2016-11-26 | Cisplatin + Radiotherapy | 01 | N | CISPLATIN | 101688712 |
| 190005630 | 190001090 | 1.84 | 67.1 | Curative (C) | 2019-03-17 | 2019-04-02 | Doxorubicin + Ifosfamide | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100100013 |